Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment

[1]  L. Becker,et al.  Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak–Stat5 Pathway , 2007, Circulation research.

[2]  D. Busch,et al.  Chemokine Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood: A Critical Role for P-Selectin Expressed on Activated Platelets , 2007, Circulation.

[3]  S. Bevan,et al.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[4]  S. McQuaid,et al.  Upregulation of ADAM-17 expression in active lesions in multiple sclerosis , 2006, Multiple sclerosis.

[5]  S. K. Park,et al.  Resveratrol Suppresses Tumor Necrosis Factor-α-Induced Fractalkine Expression in Endothelial Cells , 2006, Molecular Pharmacology.

[6]  Steffen Jung,et al.  The FASEB Journal • Research Communication The neuronal chemokine CX3CL1/fractalkine , 2022 .

[7]  N. Miyasaka,et al.  Inhibition of CX3CL1 (Fractalkine) Improves Experimental Autoimmune Myositis in SJL/J Mice1 , 2005, The Journal of Immunology.

[8]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  H. Lassmann,et al.  CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin , 2005, Journal of Neuroinflammation.

[10]  M. Woodroofe,et al.  ADAM-17 and TIMP3 protein and mRNA expression in spinal cord white matter of rats with acute experimental autoimmune encephalomyelitis , 2005, Journal of Neuroimmunology.

[11]  R. Black,et al.  Tumour necrosis factor‐α stimulates expression of TNF‐α converting enzyme in endothelial cells , 2004 .

[12]  U. Walter,et al.  Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. , 2004, Blood.

[13]  G. Davies-Jones,et al.  Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells , 2003, Journal of Neuroimmunology.

[14]  R. Ravid,et al.  CX3CL1 and CX3CR1 Expression in Human Brain Tissue: Noninflammatory Control versus Multiple Sclerosis , 2003, Journal of neuropathology and experimental neurology.

[15]  F. Fahrenholz,et al.  The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. , 2003, Blood.

[16]  F. Luscinskas,et al.  Fractalkine Preferentially Mediates Arrest and Migration of CD16+ Monocytes , 2003, The Journal of experimental medicine.

[17]  H. Hartung,et al.  CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system , 2003, Journal of Neuroimmunology.

[18]  D. Huszar,et al.  Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury , 2002, Journal of Neuroimmunology.

[19]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[20]  I. Charo,et al.  Tumor Necrosis Factor- (cid:1) -converting Enzyme Mediates the Inducible Cleavage of Fractalkine* , 2022 .

[21]  C. Blobel,et al.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.

[22]  M. Woodroofe,et al.  Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS , 2001, Glia.

[23]  P. Slocombe,et al.  The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3 , 2000, FEBS letters.

[24]  R. Ye,et al.  NF‐κB‐dependent fractalkine induction in rat aortic endothelial cells stimulated by IL‐1β, TNF‐α, and LPS , 2000 .

[25]  R. Black,et al.  Adamalysins: A Family of Metzincins Including TNF‐α Converting Enzyme (TACE) , 1999 .

[26]  P. Slocombe,et al.  TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 , 1998 .

[27]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[28]  R. Huber,et al.  Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 , 1997, Nature.

[29]  J. Gutiérrez-Ramos,et al.  Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation , 1997, Nature.

[30]  M. Lambert,et al.  Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.

[31]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[32]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[33]  W. Brück,et al.  Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells , 1995, Journal of Neuroimmunology.